Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.
Infection with Epstein-Barr virus (EBV) is initiated by virus binding to the C3dg-C3d receptor CR2. Several workers have implicated this receptor in the control of B-cell activation by examining the effects of antibodies to CR2 and isolated C3d on B-cell proliferation and differentiation. We report...
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1987
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC254019/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3027404/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.61.3.774-781.1987 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|